A Study to Evaluate Safety and Tolerability of Olipudase Alfa in Pediatric and Adult Participants With Acid Sphingomyelinase Deficiency (ASMD) Who Completed the DFI12712 or the LTS13632 Study in France
Clinical trial NCT06949358 · COMPLETED
Trial details
- NCT number
- NCT06949358
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-18
- Primary completion
- 2025-04-08
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.